Sarepta Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC SRPT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

765,383

Value ($000)

16,471

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	16,471	0.0%	765,383	12/31/2025
2025 Q3	11/10/2025	11,738	0.0%	609,151	9/30/2025
2025 Q2	8/12/2025	11,523	0.0%	673,877	6/30/2025
2025 Q1	9/15/2025	41,246	0.0%	646,291	3/31/2025
2024 Q4	2/6/2025	75,842	0.0%	623,749	12/31/2024
2024 Q3	11/12/2024	76,401	0.0%	611,749	9/30/2024
2024 Q2	8/12/2024	95,552	0.0%	604,757	6/30/2024
2024 Q1	5/9/2024	76,309	0.0%	589,439	3/31/2024
2023 Q4	2/6/2024	55,583	0.0%	576,412	12/31/2023
2023 Q3	11/8/2023	67,926	0.0%	560,351	9/30/2023
2023 Q2	8/10/2023	63,449	0.0%	554,042	6/30/2023
2023 Q1	5/12/2023	71,667	0.0%	519,964	3/31/2023
2022 Q4	2/13/2023	66,923	0.0%	516,459	12/31/2022
2022 Q3	11/14/2022	54,678	0.0%	494,640	9/30/2022
2022 Q2	8/15/2022	36,555	0.0%	487,654	6/30/2022
2022 Q1	5/13/2022	37,442	0.0%	479,285	3/31/2022
2021 Q4	2/11/2022	42,169	0.0%	468,279	12/31/2021
2021 Q3	11/16/2021	38,718	0.0%	418,659	9/30/2021
2021 Q2	8/16/2021	31,391	0.0%	403,793	6/30/2021
2021 Q1	5/17/2021	29,398	0.0%	394,432	3/31/2021
2020 Q4	2/16/2021	66,568	0.0%	390,449	12/31/2020
2020 Q3	11/13/2020	53,994	0.0%	384,487	9/30/2020
2020 Q2	8/20/2020	57,752	0.0%	360,179	6/30/2020
2020 Q1	5/15/2020	33,064	0.0%	338,001	3/31/2020
2019 Q4	2/7/2020	42,686	0.0%	330,791	12/31/2019
2014 Q2	7/30/2014	3,191	0.0%	107,112	6/30/2014
2014 Q1	4/29/2014	2,345	0.0%	97,552	3/31/2014
2013 Q4	2/14/2014	1,828	0.0%	89,728	12/31/2013